PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.\', \'Center for Research in Evaluation and Surveys, National Institute of Public Health, Cuernavaca, Mexico.\', \'Center for Research on Infectious Diseases, National Institute of Public Health, Cuernavaca, Mexico.\', \'Institute for Epidemiological Diagnosis and Reference, Mexico City, Mexico.\', \'National Institute of Public Health, Cuernavaca, Mexico.\', \'Center for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico. tbarrientos@insp.edu.mx.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-022-28232-9
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 35105873
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35105873>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35105873>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all